Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04537416 · ClinicalTrials.gov registry record
Fertility, Hypercoagulability, and Inflammation (FREYA) Registry
A clinical trial of Thrombophilia, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT04537416: Active study of Thrombophilia, sponsored by Brigham and Women's Hospital.
NCT04537416 is a study of Thrombophilia that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04537416, a study of Thrombophilia, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A PubMed search of "thrombophilia" and "infertility" yields only 98 articles, the majority found in foreign medical journals and subspecialty journals with narrow readerships. Outside of Assisted Reproduction Clinics at academic medical centers, health care providers have limited awareness of the literature supporting thrombophilia evaluation and treatment in patients with recurrent pregnancy loss. As a result, women may suffer through years of repeated miscarriages before a thrombophilia evaluation is performed. By the time thrombophilia has been diagnosed as the cause of recurrent pregnancy loss, couples have often exhausted their personal savings on costly assisted reproductive therapies and present frustrated and psychologically exhausted. In this study, we will evaluate the frequency of thrombophilia as a cause of recurrent pregnancy loss and provide insights into our patient care experience at BWH.
Primary Outcome
Laboratory diagnosed acquired or inherited thrombophilia
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT04537416 still lists
NCT04537416 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Thrombophilia appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT04537416 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04537416 about?
NCT04537416 is a clinical study titled "Fertility, Hypercoagulability, and Inflammation (FREYA) Registry". A PubMed search of "thrombophilia" and "infertility" yields only 98 articles, the majority found in foreign medical journals and subspecialty journals with narrow readerships. Outside of Assisted Reproduction Clinics at academic medical centers, health care providers have limited awareness of the li...
What is the current status of trial NCT04537416?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2018-04-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04537416 study?
This clinical trial studies the following conditions: Thrombophilia.
What interventions are being tested in trial NCT04537416?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04537416?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04537416 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombophilia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI